DIRS.INFO The most relevant business & tech news

☆ A $7.40 fee could ruin your next trip to Europe. Miss it and 'you won't board the plane,’ expert says
▼ + stars: | 2023-10-19 | by ( Greg Iacurci | ) www.cnbc.com time to read: +1 min

Americans will soon have to apply for a travel authorization to visit Europe — and failing to get one may ruin your next trip. The requirement, slated to start in 2024, currently applies to 30 European nations, including popular destinations like France, Germany, Greece, Italy, Portugal and Spain. Travelers must apply for the travel authorization via the European Travel Information and Authorisation System, or ETIAS, prior to their trip. The online application carries a non-refundable fee of 7 euros a person — or $7.40 at prevailing exchange rates as of 12 noon ET on Thursday. "If you forget to do it, you won't board the plane," said Sofia Markovich, a travel advisor and founder of Sofia's Travel.

Persons: Sofia Markovich Organizations: Europe —, European Travel, Finance, Sofia's Locations: Europe, France, Germany, Greece, Italy, Portugal, Spain, U.S

☆ Blue Shield of California drops CVS, taps Amazon and others to lower drug costs
▼ + stars: | 2023-08-17 | by ( ) www.reuters.com time to read: +2 min

CVS Health logo is seen displayed in this illustration taken, May 3, 2022. Blue Shield, whose health plans cover 4.8 million members, said it will now work with five different companies, including Mark Cuban's drug company, to provide "convenient, transparent access to medications while lowering costs." Privately held Abarca will pay prescription drug claims, while Prime Therapeutics will work with Blue Shield to negotiate savings with drugmakers, the company said. Blue Shield will also work with CVS Caremark for specialty pharmacy services. The loss of the Blue Shield pharmacy benefit management contract is another blow to Caremark, which is also set to lose the contract to manage Centene's (CNC.N) $40 billion annual pharmacy needs from next year.

Persons: Dado Ruvic, UnitedHealth, Mark Cuban's, Paul Markovich, Mark, Manas Mishra, Mariam Sunny, Bhanvi, Shweta Agarwal, Pooja Desai Organizations: CVS, REUTERS, Blue, Cigna, UnitedHealth, Pharmacy, Wall Street, Mark Cuban, Plus, Thomson Locations: Blue, Bengaluru

☆ Blue Shield of California taps Amazon, Mark Cuban's Cost Plus Drugs for its pharmacy network
▼ + stars: | 2023-08-17 | by ( Bertha Coombs | ) www.cnbc.com time to read: +2 min

Blue Shield of California is teaming up with Mark Cuban's Cost Plus Drug Company and Amazon Pharmacy — turning away from traditional drug store chains and ditching in part health giant CVS — in a move to save on drug costs for its 4.8 million members. "I expect we're going to — when this ramps up completely — we're going to be saving $500 million a year," said Paul Markovich, CEO of Blue Shield of California. For Cost Plus, which sells drugs at 15% above wholesale prices, California Blue Shield is only the second insurer to sign with the online pharmacy since it launched in January 2022. "I think all payers realize that now that Cost Plus has made the price of medications transparent. The health insurer expects to launch the program for its members in 2025.

Persons: Mark Cuban's, Paul Markovich, Markovich Organizations: Drug Company, Amazon Pharmacy, CVS, Blue, of, Cross Locations: of California, California, Harrisburg , Pennsylvania

☆ CVS stock plunges after Blue Shield of California drops retailer's pharmacy services to save on drug costs
▼ + stars: | 2023-08-17 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Shares of CVS Health plunged 9% on Thursday after Blue Shield of California said it will drop the company's pharmacy benefit management services and instead partner with Mark Cuban's Cost Plus Drug Company and Amazon Pharmacy to save on drug costs for its nearly 5 million members. Blue Shield will now work with five different companies to provide "convenient, transparent access to medications while lowering costs." Blue Shield CEO Paul Markovich said the plan, which is scheduled to fully launch in 2025, could save the company up to $500 million annually. Cuban's Cost Plus Drug Company will provide access to low-cost medications through retail pharmacies. Blue Shield will retain CVS Caremark for its specialty pharmacy services, which provide specialized therapies and counseling to patients suffering from complex disorders.

Persons: Mark Cuban's, Caremark, Paul Markovich, Michael DeAngelis, Centene Organizations: CVS Health, Drug Company, Amazon Pharmacy, UnitedHealth, CVS, Abarca, Blue, CNBC Locations: New York, California

Blue Shield of California will no longer use CVS Health’s Caremark as its pharmacy benefit manager and instead will partner with several companies, including Amazon Pharmacy and Mark Cuban Cost Plus Drug Company. They have come under fire from other players in the health care industry and from Congress because of their opaque practices. Most adults take at least one prescription drug annually, while more than a third take at least three, Blue Shield said, citing Centers for Disease Control and Prevention data. CVS Caremark will continue to work with Blue Shield, providing specialty pharmacy services for members with complex conditions. The company bought online pharmacy PillPack in 2018, launched its own Amazon Pharmacy in 2020 and last year created a virtual health care clinic.

Persons: ” Paul Markovich, Mark Organizations: New, New York CNN, CVS, Amazon Pharmacy, Cuban, Plus Drug Company, Pharmacy, Blue, for Disease Control, ”, Mark Cuban, Plus, CVS Health, Amazon Locations: New York, California

But the plunge in the deal pipeline prompted soul-searching and job-hopping among investment bankers accustomed to a feast. Barclays, which has struggled to retain bankers following a shake-up in the management of its investment banking division, has lost at least nine top technology bankers in recent weeks. Traditionally, smaller firms have been reluctant to offer investment bankers guaranteed compensation, in order to have more of their pay tied to performance. Alan Johnson, managing director of compensation consultancy Johnson Associates, said that first-year guarantees were common practice in the hiring of investment bankers, but second-year guarantee used to be rare. "You get paid a higher percentage of revenue than in a big bank, but you have to generate the revenue with perhaps less help," Johnson said.

Persons: Goldman Sachs, Sam Britton, Britton, Anthony Keizner, Goldman, Nick Pomponi, Rob Chisholm, Troy Broderick, Goldman's, Perella Weinberg, Laurence Braham, Richard Hardegree, Steve Markovich, Ron Eliasek, Jason Auerbach, Alan Johnson, Johnson, Milana Vinn, Anirban Sen, Greg Roumeliotis, Jamie Freed Organizations: YORK, Goldman, Bank of America, Barclays, Qatalyst Partners, Jefferies Financial, Technology, LSEG, Intelligence, Search, Evercore, UBS, Centerview, Jefferies, SVB Securities, Bank, Reuters, Johnson Associates, Thomson Locations: Qatalyst, New York

☆ Some travel is 'off the charts' expensive, experts say. Here are 3 ways to cut some costs
▼ + stars: | 2023-04-17 | by ( Greg Iacurci | ) www.cnbc.com time to read: +7 min

D3sign | Moment | Getty ImagesInternational travel costs have hit record highsThe Eiffel Tower and Seine River at sunrise in Paris. The so-called "revenge travel" dynamic has helped to push up prices, perhaps most acutely for travel abroad. These are record-high prices, Berg said. People should be prepared not just for a busy travel season, but an expensive travel season. Sally French travel expert at NerdWalletThis summer is expected to be the busiest on record for international travel, the U.S. State Department said in March.

☆ Viktor Bout: The Russian arms dealer swapped for Brittney Griner
▼ + stars: | 2022-12-08 | by ( Eliza Mackintosh | ) edition.cnn.com time to read: +5 min

CNN —Brittney Griner’s freedom ultimately hinged on the release of a convicted Russian arms dealer whose life story inspired a Hollywood film. On Thursday, a source told CNN that the US basketball star had been released from Russian detention in a prisoner swap for Viktor Bout, nicknamed the “Merchant of Death” by his accuser. Viktor Bout is pictured in a temporary cell ahead of a hearing at a court in Bangkok in August 2010. Christophe Archambault/AFP/Getty Images“His early days are a mystery,” Douglas Farah, a senior fellow at the International Assessment and Strategy Center who co-authored a book on Bout, told CNN in 2010. He said that Bout graduated from the Military Institute on Foreign Languages, a well-known feeder school for Russian military intelligence.

Search resuls for: "Markovich"

8 mentions found